Sign in
4

Changes in Ownership

bioAffinity Technologies, Inc. Filed Acc 0001493152-23-023818

Chief Financial Officer acquired 52,356 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dougherty Michael Philip · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-06 Grant or award : show line 1 in the form +52,356 $1.91 $100,000 52,356 D
Loading xslF345X04/ownership.xml…